Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 9 Genitourinary 6 Gastrointestinal 5 Tumor-Agnostic 3 Thoracic 3 Head & Neck 3 Gynecologic 3 Other hematologic neoplasm 2 Lymphoid 2 Plasma cell 1 Other 1 Dermatologic 1 CNS 1

Conditions

Sexual Dysfunction, Physiological 1

Interventions

Surveys and Questionnaires 9 Blood Specimen Collection 5 naloxegol 3 Therapeutics 3 Observation 3 Interviews as Topic 3 Bariatric Surgery 3 naldemedine 2 exemestane 2 Tirzepatide 2 Tamoxifen 2 Psychiatric Rehabilitation 2 Paclitaxel 2 Hematologic Tests 2 Esophagectomy 2 Echocardiography 2 Carboplatin 2 Biopsy 2 BaseLine dental cement 2 Anastrozole 2 trametinib 1 sotorasib 1 semaglutide 1 selpercatinib 1 pembrolizumab 1 osimertinib 1 lorlatinib 1 dabrafenib 1 cemiplimab 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Focus Groups × Other × Clear all

NCT00614276 2015-01-09

Female Sexual Dysfunction Intervention

M.D. Anderson Cancer Center

Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon ⚡